Priya S. Chockalingam

Company: Beam Therapeutics Inc.
Job title: Vice President, Head, Clinical Bioanalytics & Translational Sciences
Seminars:
Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease 2:45 pm
Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease Specialized biomarker discovery to assess disease pathophysiology Importance and opportunity biomarkers bring to accelerate clinical developmentRead more
day: Day Two